Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Crinetics Pharmaceuticals Inc buy Piper Sandler

Crinetics Pharmaceuticals Inc
Start price
€42.40
02.07.24 / 50%
Target price
€90.28
02.07.25
Performance (%)
-41.51%
End price
€24.80
03.07.25
Summary
This prediction ended on 03.07.25 with a price of €24.80. The BUY prediction by Piper_Sandler for Crinetics Pharmaceuticals Inc performed very badly with a performance of -41.51%. Piper_Sandler has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Crinetics Pharmaceuticals Inc 0.387% 0.387% 203.000%
iShares Core DAX® 2,57 % 3,50 % 8,41 %
iShares Nasdaq 100 4,86 % 0,65 % 28,38 %
iShares Nikkei 225® 5,59 % -0,25 % 52,92 %
iShares S&P 500 3,25 % 2,08 % 24,37 %

Comments by Piper_Sandler for this prediction

In the thread Crinetics Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) -41.51%
Target price 90.278
Change
Ends at 02.07.25

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $97.00 price target on the stock.
Ratings data for CRNX provided by MarketBeat

Piper Sandler 
0
Report Share
02.07.24
In the thread Trading Crinetics Pharmaceuticals Inc
Prediction Buy
Perf. (%) -41.51%
Target price 90.278
Change
Ends at 02.07.25

Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten

Piper Sandler 
0
Report Share
03.07.25

Stopped prediction by Piper_Sandler for Crinetics Pharmaceuticals Inc

buy
Crinetics Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€44.40
07.05.24
€89.99
07.05.25
-37.39%
08.05.25

Piper Sandler 
07.05.24 50%